SHARP SHALINI 1377202 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-06-13 2023-06-09 4 Sharp Shalini DIRECTOR holding 2.0 0 0.0 Direct Common Stock ORGANON & CO.

code_

NA
255.06 (OGN)
2024-01-03 2023-12-29 2023-12-29 4 Sharp Shalini DIRECTOR acq 6808.0 41.97 0.97 58.75 Direct Common Stock MIRATI THERAPEUTICS, INC.

code_A

code  A
16222.0 70.15 (MRTX)
2024-01-23 2024-01-23 2024-01-23 4 Sharp Shalini DIRECTOR dsp 16222.0 100.0 2.31 0.0 Direct Common Stock MIRATI THERAPEUTICS, INC.

code_D

code  D
0.0 thumbnail 70.15 (MRTX)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-05-19 2023-05-17 2023-05-17 4 Sharp Shalini DIRECTOR acq 4290.0 100.0 0.44 95.27 Direct Non Qualified Stock Option NEUROCRINE BIOSCIENCES INC

code_A

code  A
4290.0 97.57 (NBIX)
2023-05-19 2023-05-17 2023-05-17 4 Sharp Shalini DIRECTOR acq 2100.0 100.0 0.22 0.0 Direct Restricted Stock Unit NEUROCRINE BIOSCIENCES INC

code_A

code  A
2100.0 97.57 (NBIX)
2023-06-13 2023-06-09 2023-06-09 4 Sharp Shalini DIRECTOR acq 10086.0 39.41 0.4 19.83 Direct Phantom Stock ORGANON & CO.

code_A

code  A
25594.0 255.06 (OGN)
2024-01-23 2024-01-23 2024-01-23 4 Sharp Shalini DIRECTOR dsp 7520.0 100.0 1.07 45.66 Direct Option To Purchase Common Stock MIRATI THERAPEUTICS, INC.

code_D

code  D
0.0 70.15 (MRTX)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)